2014
DOI: 10.1016/s1665-2681(19)30916-0
|View full text |Cite
|
Sign up to set email alerts
|

Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…The cardiac manifestations are often well‐characterized, while systemic vascular amyloidosis seems to represent an under‐recognized condition. Occasionally, amyloid angiopathy has been reported to cause, for example, ocular problems in familial TTR amyloidosis or pulmonary hypertension in AL amyloidosis . Furthermore, systematic studies in AL patients, who often have widespread vascular amyloidosis, revealed significant vascular and endothelial dysfunction .…”
Section: Discussionmentioning
confidence: 99%
“…The cardiac manifestations are often well‐characterized, while systemic vascular amyloidosis seems to represent an under‐recognized condition. Occasionally, amyloid angiopathy has been reported to cause, for example, ocular problems in familial TTR amyloidosis or pulmonary hypertension in AL amyloidosis . Furthermore, systematic studies in AL patients, who often have widespread vascular amyloidosis, revealed significant vascular and endothelial dysfunction .…”
Section: Discussionmentioning
confidence: 99%
“…Hepatic dysfunction is usually clinically silent with normal or mildly abnormal liver function tests [8]. A few cases of acute or subacute hepatic failure have previously been reported in AL amyloidosis with multiple myeloma [8][9][10][11][12][13][14][15][16][17].…”
Section: Discussionmentioning
confidence: 99%
“…In an autopsy series [ 4 ], 70% of the patients with primary systemic amyloidosis had liver involvement, which is, however, most of the times asymptomatic. There are few reported cases of portal hypertension due to primary systemic amyloidosis [ 5 - 6 ]. Notably, liver involvement is associated with a reduced survival in patients with primary systemic amyloidosis (mean survival time: 10 to 14 months vs. 12 to 18 months in patients without liver involvement) [ 7 - 9 ] and the presence of portal hypertension further worsens patients’ outcome (mean survival time: eight to nine months) [ 10 ].…”
Section: Discussionmentioning
confidence: 99%